Blank Cover Image

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis

フォーマット:
論文
責任表示:
Kita, Yuki ; Takamura, Toshinari ; Misu, Hirofumi ; Ota, Tsuguhito ; Kurita, Seiichiro ; Takeshita, Yumie ; Uno, Masafumi ; Matsuzawa-Nagata, Naoto ; Kato, Ken-ichiro ; Ando, Hitoshi ; Fujimura, Akio ; Hayashi, Koji ; Kimura, Toru ; Ni, Yinhua ; Otoda, Toshiki ; Miyamoto, Ken-ichi ; Zen, Yoh ; Nakanuma, Yasuni ; Kaneko, Shuichi
言語:
英語
出版情報:
Public Library of Science, 2012-09-18
著者名:
Kita, Yuki
Takamura, Toshinari
Misu, Hirofumi
Ota, Tsuguhito
Kurita, Seiichiro
Takeshita, Yumie
Uno, Masafumi
Matsuzawa-Nagata, Naoto
Kato, Ken-ichiro
Ando, Hitoshi
Fujimura, Akio
Hayashi, Koji
Kimura, Toru
Ni, Yinhua
Otoda, Toshiki
Miyamoto, Ken-ichi
Zen, Yoh
Nakanuma, Yasuni
Kaneko, Shuichi
続きを見る
掲載情報:
PLoS ONE
ISSN:
1932-6203  CiNii Research  Webcat Plus  JAIRO
巻:
7
通号:
9
開始ページ:
e43056
バージョン:
publisher
概要:
Background: Optimal treatment for nonalcoholic steatohepatitis (NASH) has not yet been established, particularly for individuals without diabetes. We examined the effects of metformin, commonly used to treat patients with type 2 diabetes, on liver pathology in a non-diabetic NASH mouse model. Methodology/Principal Findings: Eight-week-old C57BL/6 mice were fed a methionine- and choline-deficient plus high fat (MCD+HF) diet with or without 0.1% metformin for 8 weeks. Co-administration of metformin significantly decreased fasting plasma glucose levels, but did not affect glucose tolerance or peripheral insulin sensitivity. Metformin ameliorated MCD+HF diet-induced hepatic steatosis, inflammation, and fibrosis. Furthermore, metformin significantly reversed hepatic steatosis and inflammation when administered after the development of experimental NASH. Conclusions/Significance: These histological changes were accompanied by reduced hepatic triglyceride content, suppressed hepatic stellate cell activation, and the downregulation of genes involved in fatty acid metabolism, inflammation, and fibrogenesis. Metformin prevented and reversed steatosis and inflammation of NASH in an experimental non-diabetic model without affecting peripheral insulin resistance. © 2012 Kita et al. 続きを見る
URL:
http://hdl.handle.net/2297/32834
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Uno, Masafumi, Kurita, Seiichiro, Misu, Hirofumi, Ando, Hitoshi, Ota, Tsuguhito, Matsuzawa-Nagata, Naoto, Kita, Yuki, …

John Wiley & Sons

Misu, Hirofumi, Takamura, Toshinari, Takayama, Hiroaki, Hayashi, Hiroto, Matsuzawa-Nagata, Naoto, Kurita, Seiichiro, …

Elsevier

Kurita, Seiichiro, Takamura, Toshinari, Ota, Tsuguhito, Matsuzawa-Nagata, Naoto, Kita, Yuki, Uno, Masafumi, Nabemoto, …

Elsevier

Nakamura, Seiji, Takamura, Toshinari, Matsuzawa-Nagata, Naoto, Takayama, Hiroaki, Misu, Hirofumi, Noda, Hiroyo, …

American Society for Biochemistry and Molecular Biology

Ando, Hitoshi, Takamura, Toshinari, Matsuzawa-Nagata, Naoto, Shima, Kosuke R., Nakamura, Seiji, Kumazaki, Masafumi, …

Elsevier

Ando, Hitoshi, Kurita, Seiichiro, Shimizu, Akiko, Kato, Ken-ichiro, Ishikura, Kazuhide, Taji, Koumei, Uno, Masafumi, …

Blackwell

Matsuzawa-Nagata, Naoto, Takamura, Toshinari, Ando, Hitoshi, Nakamura, Seiji, Kurita, Seiichiro, Misu, Hirofumi, Ota, …

Elsevier

Misu, Hirofumi, Ishikura, Kazuhide, Kurita, Seiichiro, Takeshita, Yumie, Ota, Tsuguhito, Saito, Yoshiro, Takahashi, …

PLoS ONE

Ishikura, Kazuhide, Misu, Hirofumi, Kumazaki, Masafumi, Takayama, Hiroaki, Matsuzawa-Nagata, Naoto, Tajima, Natsumi, …

Springer Verlag

Lan, Fei, Misu, Hirofumi, Chikamoto, Keita, Takayama, Hiroaki, Kikuchi, Akihiro, Mohri, Kensuke, Takata, Noboru, …

American Diabetes Association

Ni, Yinhua, Nagashimada, Mayumi, Zhuge, Fen, Zhan, Lili, Nagata, Naoto, Tsutsui, Akemi, Nakanuma, Yasuni, Kaneko, …

Nature Publishing Group

Hamaguchi, Erika, Takamura, Toshinari, Sakurai, Masaru, Mizukoshi, Eishiro, Zen, Yoh, Takeshita, Yumie, Kurita, …

American Diabetes Association